Clinical translational award: This supports translational research addressing high-impact ideas or unmet needs in ovarian cancer. Awards are worth up to USD 450,000 each over a maximum period of three years.  Click here to learn more.

Investigator-initiated research award: This supports patient-centred research to prevent, detect, treat and cure ovarian cancer. Awards are worth up to USD 800,000 each for up to four years.  Click here to learn more.

Pilot award: This supports innovative ovarian cancer research that could ultimately lead to critical discoveries or major advancements that will drive the field forward. Awards are worth up to USD 250,000 each for two years.  Click here to learn more.

Proteogenomics research award: This supports the use of proteomics and genomics to explore innovative new concepts or theories in ovarian cancer that have the potential to make an impact on future research or patient and survivor care. Awards are worth up to USD 250,000 each for up to two years.  Click here to learn more.

Early-career investigator award: This enables early-career investigators to pursue an ovarian cancer project that may involve basic, translational or clinical research, or a clinical trial, under the guidance of a designated mentor. Awards are worth up to USD 725,000 each over a maximum period of four years.  Click here to learn more.